This inventor holds 1 USPTO granted patent. Top assignees: Boston University, University of Florida Research Foundation Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025
Title: Yu Zhou: Innovator in RNA Interference Technology
Introduction
Yu Zhou is a prominent inventor based in Gainesville, FL (US). He has made significant contributions to the field of molecular biology, particularly in the area of RNA interference. His innovative work focuses on developing methods and systems that enhance the control of gene expression through synthetic nucleic acid molecules.
Latest Patents
Yu Zhou holds a patent for "miRNA switches for RNA-triggered control of RNA interference." This patent describes methods, compositions, and systems that utilize synthetic nucleic acid molecules to enable inducible or conditional pri-miRNA processing in mammalian cells in vivo. The technology, referred to as Orthogonal RNA Interference induced by Trigger RNA (ORIENTR), allows for the switching between inactive and active forms upon interaction with specific RNA-trigger molecules. This advancement has the potential to facilitate RNAi-mediated repression of target genes, offering new avenues for disease treatment and detection.
Career Highlights
Throughout his career, Yu Zhou has worked with esteemed institutions such as Boston University and the University of Florida Research Foundation. His research has contributed to the understanding and application of RNA interference technology, positioning him as a key figure in this innovative field.
Collaborations
Yu Zhou has collaborated with notable colleagues, including Alexander A Green and Peike Sheng. These partnerships have furthered his research and expanded the impact of his inventions in the scientific community.
Conclusion
Yu Zhou's contributions to RNA interference technology exemplify the power of innovation in addressing complex biological challenges. His work not only advances scientific understanding but also holds promise for future therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile